Precigen

Precigen, Inc is an American biotechnology company.
Precigen stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Precigen balance sheet

Report period2016 2017 2018 2019 2020 2021
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Precigen cash flows

Report period2016 2017 2018 2019 2020 2021
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Precigen multipliers

Report period2016 2017 2018 2019 2020 2021
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Precigen profitability

Report period2016 2017 2018 2019 2020 2021
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Precigen assets
Precigen cash flows

Precigen shares

TickerNameTypeNominal valueISINPrice
PGEN:USPrecigenCommon share-US74017N1054$1.33
Precigen news
10.05.2022
Precigen's GAAP loss for 3 months of 2022 was $19.251 million, up 11.2% from $17.318 million in the prior year. Revenue increased 30.6% to $32.021 million from $24.511 million a year earlier.
01.03.2022
Precigen's GAAP loss for 2021 was $92.166 million, down 46% from $170.521 million the previous year. Revenue increased 0.7% to $103.873 million from $103.178 million a year earlier.
09.08.2021
Precigen's GAAP loss for 6M 2021 was $37.368 million, down 2.7 times from $99.352 million in the previous year. Revenue fell 3.6% to $58.091 million from $60.262 million a year earlier.
11.05.2021
Precigen's GAAP loss for 3 months of 2021 was $17.318 million, down 69.1% from $55.998 million in the prior year. Revenue declined 17.9% to $24.511 million from $29.838 million a year earlier.
General information
Company namePrecigen
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
Mailing address20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Websitewww.precigen.com
Information disclosurewww.sec.gov